Your browser doesn't support javascript.
loading
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma.
Nicolle, R; Gayet, O; Duconseil, P; Vanbrugghe, C; Roques, J; Bigonnet, M; Blum, Y; Elarouci, N; Armenoult, L; Ayadi, M; de Reyniès, A; Puleo, F; Augustin, J; Emile, J F; Svrcek, M; Arsenijevic, T; Hammel, P; Giovannini, M; Grandval, P; Dahan, L; Moutardier, V; Gilabert, M; Van Laethem, J L; Bachet, J B; Cros, J; Iovanna, J; Dusetti, N J.
Affiliation
  • Nicolle R; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France.
  • Gayet O; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France.
  • Duconseil P; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France; Nord Hospital, Marseille, France.
  • Vanbrugghe C; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France; Nord Hospital, Marseille, France.
  • Roques J; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France.
  • Bigonnet M; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France.
  • Blum Y; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France.
  • Elarouci N; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France.
  • Armenoult L; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France.
  • Ayadi M; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France.
  • de Reyniès A; Tumour Identity Card Program (CIT), French League Against Cancer, Paris, France.
  • Puleo F; Laboratory of Experimental Gastroenterology (Université Libre de Bruxelles), Brussels, Belgium; Department of Gastroenterology and Digestive Oncology, Delta Hospital, Center Hospitalier Interregional Edith Cavell, Brussels, Belgium.
  • Augustin J; Sorbonne University, UPMC University, Department of Gastroenterology, Pitié-Salpetriére Hospital, Paris, France.
  • Emile JF; Ambroise Paré Hospital, Boulogne, AP-HP, Boulogne-Billancourt, France.
  • Svrcek M; Sorbonne University, UPMC University, Department of Gastroenterology, Pitié-Salpetriére Hospital, Paris, France.
  • Arsenijevic T; Laboratory of Experimental Gastroenterology (Université Libre de Bruxelles), Brussels, Belgium; Department of Gastroenterology and Digestive Oncology, Delta Hospital, Center Hospitalier Interregional Edith Cavell, Brussels, Belgium.
  • Hammel P; Department of Digestive Oncology, Beaujon Hospital, Paris 7 University, APHP, Clichy, France.
  • Giovannini M; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France; Paoli-Calmettes Institut, Marseille, France.
  • Grandval P; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France; La Timone Hospital, Marseille, France.
  • Dahan L; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France; La Timone Hospital, Marseille, France.
  • Moutardier V; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France; Nord Hospital, Marseille, France.
  • Gilabert M; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France; Paoli-Calmettes Institut, Marseille, France.
  • Van Laethem JL; Laboratory of Experimental Gastroenterology (Université Libre de Bruxelles), Brussels, Belgium; Department of Gastroenterology and Digestive Oncology, Delta Hospital, Center Hospitalier Interregional Edith Cavell, Brussels, Belgium.
  • Bachet JB; Sorbonne University, UPMC University, Department of Gastroenterology, Pitié-Salpetriére Hospital, Paris, France.
  • Cros J; Department of Digestive Oncology, Beaujon Hospital, Paris 7 University, APHP, Clichy, France.
  • Iovanna J; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France. Electronic address: juan.iovanna@inserm.fr.
  • Dusetti NJ; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France. Electronic address: nelson.dusetti@inserm.fr.
Ann Oncol ; 32(2): 250-260, 2021 02.
Article in En | MEDLINE | ID: mdl-33188873
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Carcinoma, Pancreatic Ductal Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Carcinoma, Pancreatic Ductal Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2021 Document type: Article